Yamase T - Search Results

1

Anticancer activity of polyoxomolybdate.

Yanagie H, Ogata A, Mitsui S, Hisa T, Yamase T, Eriguchi M. Yanagie H, et al. Among authors: yamase t. Biomed Pharmacother. 2006 Aug;60(7):349-52. doi: 10.1016/j.biopha.2006.06.018. Epub 2006 Jun 30. Biomed Pharmacother. 2006. PMID: 16860529 Review.

2

Enhancement of antibacterial activity of beta-lactam antibiotics by [P2W18O62]6-, [SiMo12O40]4-, and [PTi2W10O40]7- against methicillin-resistant and vancomycin-resistant Staphylococcus aureus.

Inoue M, Suzuki T, Fujita Y, Oda M, Matsumoto N, Yamase T. Inoue M, et al. Among authors: yamase t. J Inorg Biochem. 2006 Jul;100(7):1225-33. doi: 10.1016/j.jinorgbio.2006.02.004. Epub 2006 Mar 23. J Inorg Biochem. 2006. PMID: 16563513

3

Enhancement effect of polyoxometalates on NGF-induced neurite-outgrowth of PC12 cells.

Oda M, Inoue M, Hino K, Nakamura Y, Yamase T. Oda M, et al. Among authors: yamase t. Biol Pharm Bull. 2007 Apr;30(4):787-90. doi: 10.1248/bpb.30.787. Biol Pharm Bull. 2007. PMID: 17409521

4

Prevention of the interaction between HVEM, herpes virus entry mediator, and gD, HSV envelope protein, by a Keggin polyoxotungstate, PM-19.

Dan K, Yamase T. Dan K, et al. Among authors: yamase t. Biomed Pharmacother. 2006 May;60(4):169-73. doi: 10.1016/j.biopha.2006.02.005. Epub 2006 Mar 29. Biomed Pharmacother. 2006. PMID: 16675194

5

Anti-RNA virus activity of polyoxometalates.

Shigeta S, Mori S, Yamase T, Yamamoto N, Yamamoto N. Shigeta S, et al. Among authors: yamase t. Biomed Pharmacother. 2006 Jun;60(5):211-9. doi: 10.1016/j.biopha.2006.03.009. Epub 2006 May 24. Biomed Pharmacother. 2006. PMID: 16737794 Free PMC article.

6

Antitumor activity of new antitumor substance, polyoxomolybdate, against several human cancers in athymic nude mice.

Fujita H, Fujita T, Sakurai T, Yamase T, Seto Y. Fujita H, et al. Among authors: yamase t. Tohoku J Exp Med. 1992 Oct;168(2):421-6. doi: 10.1620/tjem.168.421. Tohoku J Exp Med. 1992. PMID: 1306330

7

Structure-activity correlationship and strain specificity of polyoxometalates in anti-human immunodeficiency virus activity.

Inouye Y, Fujimoto Y, Sugiyama M, Yoshida T, Yamase T. Inouye Y, et al. Among authors: yamase t. Biol Pharm Bull. 1995 Jul;18(7):996-1000. doi: 10.1248/bpb.18.996. Biol Pharm Bull. 1995. PMID: 7581257

8

Synergistic effect of polyoxotungstates in combination with beta-lactam antibiotics on antibacterial activity against methicillin-resistant Staphylococcus aureus.

Yamase T, Fukuda N, Tajima Y. Yamase T, et al. Biol Pharm Bull. 1996 Mar;19(3):459-65. doi: 10.1248/bpb.19.459. Biol Pharm Bull. 1996. PMID: 8924919

9

A novel anti-tumor agent, polyoxomolybdate induces apoptotic cell death in AsPC-1 human pancreatic cancer cells.

Ogata A, Mitsui S, Yanagie H, Kasano H, Hisa T, Yamase T, Eriguchi M. Ogata A, et al. Among authors: yamase t. Biomed Pharmacother. 2005 Jun;59(5):240-4. doi: 10.1016/j.biopha.2004.11.008. Biomed Pharmacother. 2005. PMID: 15908170

10

Synergistic effect of polyoxometalates in combination with oxacillin against methicillin-resistant and vancomycin-resistant Staphylococcus aureus: a high initial inoculum of 1 x 108 cfu/ml for in vivo test.

Inoue M, Suzuki T, Fujita Y, Oda M, Matsumoto N, Iijima J, Yamase T. Inoue M, et al. Among authors: yamase t. Biomed Pharmacother. 2006 Jun;60(5):220-6. doi: 10.1016/j.biopha.2006.04.006. Epub 2006 May 24. Biomed Pharmacother. 2006. PMID: 16757145

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results